0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Diagnosis and Localization of Brain Tumors: A Clinical and Experimental Study Employing Fluorescent and Radioactive Tracer Methods

JAMA. 1954;154(16):1395. doi:10.1001/jama.1954.02940500075035.
Text Size: A A A
Published online

ABSTRACT

This interesting monograph presents in detail the author's efforts at localizing brain tumors by substances injected into the blood stream, which lodge selectively in the tumors and are detected by various means. Most of these efforts were futile, but in two instances a certain measure of success was achieved. The first of these was the use of fluorescein, which is detected in the tumor tissue at the operating table when the tumor tissue is exposed to ultraviolet light. Of 109 tumors examined in this way, 101 fluoresced. Inflammatory tissue, cerebral cortex damaged by the application of high frequency coagulating electric current, and cerebral tissue damaged in other ways may also fluoresce. The second method is the use of suitable apparatus for the detection of radioactivity from a concentration of various radioactive substances in brain tumors. The principal substances so used were radioactive diiodofluorescein and radioactive iodinated human serum albumin. Unfortunately,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();